Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Saint Barnabas Medical Center installs ZOLL's AutoPulse Non-Invasive Cardiac Support Pump

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that Saint Barnabas Medical Center, one of the largest non-profit, non-sectarian hospitals in New Jersey, has installed the AutoPulse® Non-Invasive Cardiac Support Pump for resuscitative capabilities in the hospital's emergency department.

2 Sep 2010

Social interaction reduces physical damage to brain by heart attack: Research

A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.

31 Aug 2010

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

The advantages of prescribing angiotensin-converting enzyme (ACE) inhibitors for stable coronary artery disease (CAD) may be increased by targeting the therapy to the patients most likely to benefit.Clinical characteristics alone do not allow a reliable identification of these patients, so a research programme was carried out at Erasmus University Medical Centre in Rotterdam to develop a genetic profiling model that predicts the treatment benefits of ACE inhibitors and optimises the recommended therapy.

31 Aug 2010

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation.

31 Aug 2010

$Heparin enoxaparin may provide better outcomes than unfractionated heparin$

Heparin enoxaparin may provide better outcomes than unfractionated heparin

Results from ATOLL, a phase 3 randomised trial comparing two anticoagulants in primary PCI for ST elevation MI, show that the low molecular weight heparin enoxaparin may provide better outcomes in such cases than the traditionally used unfractionated heparin.

30 Aug 2010

Low doses of n-3 fatty acids do not reduce overall rate of major cardiovascular events

Results from the Alpha Omega Trial, a multicentre, placebo-controlled trial in men and women following myocardial infarction (MI), suggest that low doses of n-3 fatty acids given in the form of enriched margarines do not reduce the overall rate of major cardiovascular events.

30 Aug 2010

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.

26 Aug 2010

Assessment of critical illness during Emergency Medical Services care

A prediction score that included such factors as age, blood pressure, heart and respiratory rate for patients who received out-of-hospital emergency care was associated with the development of critical illness during hospitalization such as severe sepsis, the need for mechanical ventilation or death, according to a study in the August 18 issue of JAMA.

19 Aug 2010

University of Maryland researchers link 3-D CT scans to standard ablation techniques

Researchers at the University of Maryland School of Medicine in Baltimore have developed a novel 3-D imaging approach that may improve the accuracy of treatment for ventricular tachycardia, a potentially life-threatening heart rhythm disorder that causes the heart to beat too fast. The new approach couples CT images with conventional ablation techniques to eliminate erratic electrical circuits in the heart that produce arrhythmias.

19 Aug 2010

Cambridge Heart second quarter 2010 total revenue decreases 18%

Cambridge Heart, Inc., today reported results for the three and six months ended June 30, 2010. Full financial statements and corresponding commentary can be found in the Company's Form 10-Q, which is expected to be filed with the Securities and Exchange Commission on August 16, 2010.

17 Aug 2010

RhinoChill Intra-Nasal Cooling System improves survival when initiated soon after cardiac arrest

A new portable system which cools the brain via the nasal cavity may improve survival following cardiac arrest compared with standard care procedures, particularly when CPR and cooling are initiated early. Results from a recent study showed that the RhinoChill(TM) Intra-Nasal Cooling System enabled brain temperature to reach target several hours earlier than patients cooled in the emergency room. It is widely recognized that the sooner brain temperature can be reduced, the better the chances of minimizing long-term damage.

16 Aug 2010

New implantable device to prevent sudden cardiac arrest

Northwestern Memorial Hospital heart rhythm specialists recently gave a 34-year-old man a makeshift paramedic—who's always on duty—inside of his chest by implanting a device that did not require X-ray assistance and the usual snaking of wires leading to the heart. In fact, the innovative device rests just beneath the surface of the skin and its components are positioned using the patient's own anatomical landmarks.

13 Aug 2010

Eastern Pennsylvania Sudden Cardiac Arrest Association launches response team with Amish community

Underscoring that a sudden cardiac arrest emergency requires quick response and that automated external defibrillators are easy to use, the Eastern Pennsylvania Chapter of the Sudden Cardiac Arrest Association has launched a unique community response team with the Amish community of Lancaster County, Pennsylvania, at the center of a broad program that will deploy AEDs in public locations, schools and even on horse and buggies and Amish farms to protect the community's residents and visitors from the nation's leading cause of death.

12 Aug 2010

S-ICD subcutaneous implantable defibrillator restores normal heartbeat in high risk cardiac arrest

Scottsdale Healthcare is the only Arizona hospital system testing a new under-the-skin device that uses an electrical shock to interrupt possibly fatal heart rhythms, restoring a normal heartbeat for patients at high risk of sudden cardiac arrest.The first Arizona patient received the device Thursday at Scottsdale Healthcare Shea Medical Center. Scottsdale Healthcare is the only Phoenix area hospital and one of only 35 in the world participating in the study.

7 Aug 2010

Need for trained medical professionals to treat medical emergencies in high school athletes

As summer football practice gets into full swing, it's essential to be aware of the risk of exertional heat stroke (EHS) in high school athletes, according to a Safety Alert in The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

6 Aug 2010

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.

5 Aug 2010

Healthcare professionals to share therapeutic hypothermia knowledge at 'Cool It' program

Healthcare professionals are invited to 'Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patients' September 9 and 10 in Minneapolis. The conference is devoted to the fundamentals of establishing and developing a cooling program and features Minneapolis physicians and other national experts.“We are sharing what we've learned with physicians and hospitals who are just beginning therapeutic hypothermia programs and with those who want to expand existing programs.”

5 Aug 2010

ZOLL Medical receives PMDA approval to distribute AED Plus, AED Pro in Japan

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has been granted approval by the Japanese Pharmaceutical and Medical Devices Agency to import and distribute the AED Plus and AED Pro in Japan.

29 Jul 2010

New Zealand MEDSAFE approves ABRAXANE for metastatic breast cancer

Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy.

29 Jul 2010

American Red Cross encourages public to be trained in full CPR and use of AEDs

"Articles published today in The New England Journal of Medicine (NEJM) cite a pair of studies on Compression-Only Cardiopulmonary Resuscitation (CPR), sometimes called continuous chest compressions, Hands-Only CPR, or cardio cerebral resuscitation (CCR).

29 Jul 2010

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Saint Barnabas Medical Center installs ZOLL's AutoPulse Non-Invasive Cardiac Support Pump

Social interaction reduces physical damage to brain by heart attack: Research

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Heparin enoxaparin may provide better outcomes than unfractionated heparin

Low doses of n-3 fatty acids do not reduce overall rate of major cardiovascular events

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Assessment of critical illness during Emergency Medical Services care

University of Maryland researchers link 3-D CT scans to standard ablation techniques

Cambridge Heart second quarter 2010 total revenue decreases 18%

RhinoChill Intra-Nasal Cooling System improves survival when initiated soon after cardiac arrest

New implantable device to prevent sudden cardiac arrest

Eastern Pennsylvania Sudden Cardiac Arrest Association launches response team with Amish community

S-ICD subcutaneous implantable defibrillator restores normal heartbeat in high risk cardiac arrest

Need for trained medical professionals to treat medical emergencies in high school athletes

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Healthcare professionals to share therapeutic hypothermia knowledge at 'Cool It' program

ZOLL Medical receives PMDA approval to distribute AED Plus, AED Pro in Japan

New Zealand MEDSAFE approves ABRAXANE for metastatic breast cancer

American Red Cross encourages public to be trained in full CPR and use of AEDs

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in